Johnson Mathew R, Reed T Patrick, Lowe Denise K, Cahoon William D
Department of Pharmacy, Virginia Commonwealth University Health System, Richmond, VA, USA.
Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
J Pharm Pract. 2019 Oct;32(5):579-583. doi: 10.1177/0897190018759857. Epub 2018 Feb 20.
Fluid resuscitation, to restore intravascular volume and improve oxygen delivery, is a crucial step in early resuscitation efforts of patients with sepsis or septic shock. The 2016 Surviving Sepsis Campaign guidelines suggest the use of dynamic versus static measures of fluid responsiveness and fluid resuscitation with at least 30 mL/kg of intravenous crystalloid within the first 3 hours followed by fluid administration if hemodynamic factors continue to improve. Despite these recommendations, risks to this practice may exist as multiple studies have demonstrated an association between a positive fluid balance and/or administration of large fluid volume and increase in mortality. These studies are limited by variations in their methodologic design; therefore, cause and effect cannot yet be determined. Future multicenter, randomized, controlled studies that evaluate fluid balance and fluid volume need to be conducted to clarify the role of fluid administration to patients with sepsis to maximize benefits and minimize risk.
液体复苏,以恢复血管内容量并改善氧输送,是脓毒症或脓毒性休克患者早期复苏努力中的关键步骤。2016年拯救脓毒症运动指南建议使用动态而非静态的液体反应性测量方法,并在最初3小时内用至少30ml/kg的静脉晶体液进行液体复苏,若血流动力学因素持续改善则继续补液。尽管有这些建议,但这种做法可能存在风险,因为多项研究表明正液体平衡和/或大量补液与死亡率增加之间存在关联。这些研究受方法学设计差异的限制,因此因果关系尚未确定。未来需要开展多中心、随机、对照研究来评估液体平衡和液体量,以明确补液对脓毒症患者的作用,从而使益处最大化并将风险降至最低。